IRIS - Res&Arch Institutional Research Information System - Research & Archive

MENCARELLI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.990
EU - Europa 2.005
AS - Asia 1.739
SA - Sud America 272
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 7.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.927
SG - Singapore 829
UA - Ucraina 416
IE - Irlanda 401
CN - Cina 283
HK - Hong Kong 255
BR - Brasile 238
RU - Federazione Russa 227
SE - Svezia 227
IT - Italia 217
VN - Vietnam 183
DE - Germania 145
FI - Finlandia 135
FR - Francia 62
GB - Regno Unito 56
KR - Corea 55
TR - Turchia 55
CA - Canada 28
MX - Messico 24
PL - Polonia 20
RO - Romania 19
CH - Svizzera 18
IN - India 18
CZ - Repubblica Ceca 16
AR - Argentina 14
ES - Italia 12
EC - Ecuador 10
JP - Giappone 10
ZA - Sudafrica 9
AT - Austria 8
BD - Bangladesh 8
BE - Belgio 8
UZ - Uzbekistan 7
GR - Grecia 6
KE - Kenya 6
NL - Olanda 6
EU - Europa 5
CR - Costa Rica 4
ID - Indonesia 4
IQ - Iraq 4
KG - Kirghizistan 4
LB - Libano 4
PK - Pakistan 4
VE - Venezuela 4
CO - Colombia 3
LT - Lituania 3
MA - Marocco 3
PA - Panama 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
DK - Danimarca 2
JO - Giordania 2
KZ - Kazakistan 2
AU - Australia 1
BB - Barbados 1
BZ - Belize 1
CL - Cile 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PW - Palau 1
PY - Paraguay 1
SA - Arabia Saudita 1
SR - Suriname 1
Totale 7.034
Salva come PNG Salva come JPEG
Città #
Singapore 547
Chandler 481
Dublin 401
Hong Kong 255
San Mateo 224
Jacksonville 190
Ashburn 164
Wilmington 150
Dong Ket 144
Boardman 136
Altamura 119
Santa Clara 117
Medford 100
Princeton 100
Lawrence 84
Beijing 80
Moscow 75
Andover 69
Ann Arbor 66
Perugia 58
Izmir 46
New York 44
Seoul 44
Des Moines 42
Los Angeles 40
Falls Church 35
Columbus 29
Saint Petersburg 28
São Paulo 28
Helsinki 22
Munich 22
Norwalk 17
The Dalles 15
Turku 15
Ho Chi Minh City 14
San Paolo di Civitate 14
Rio de Janeiro 13
Stockholm 13
Timisoara 13
Warsaw 13
Dallas 12
Piscataway 12
Brooklyn 11
Shanghai 11
Woodbridge 11
Mexico City 10
Olomouc 10
Phoenix 10
Tokyo 10
Chennai 9
Denver 9
Houston 9
Boston 8
Brussels 8
Montreal 8
Ottawa 8
Chicago 7
London 7
Manchester 7
Toronto 7
Belo Horizonte 6
Bucharest 6
Dearborn 6
Hanoi 6
Johannesburg 6
Nairobi 6
Orem 6
San Francisco 6
Auburn Hills 5
Charlotte 5
Curitiba 5
Poplar 5
Americana 4
Ankara 4
Atlanta 4
Bishkek 4
Guangzhou 4
Guayaquil 4
Quito 4
Redwood City 4
San Jose 4
Seattle 4
Vienna 4
Buffalo 3
Campinas 3
Cape Town 3
Contagem 3
Da Nang 3
Den Haag 3
Frankfurt am Main 3
Goiânia 3
Harbin 3
Itajaí 3
Jakarta 3
Lausanne 3
New Delhi 3
Nuremberg 3
Panama City 3
Philadelphia 3
Porto Alegre 3
Totale 4.414
Salva come PNG Salva come JPEG
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 176
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice 126
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 120
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 117
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 117
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 115
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 114
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity 111
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 109
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 108
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 106
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 104
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 103
Antiatherosclerotic effect of farnesoid X receptor. 101
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 101
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 101
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 94
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 93
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 92
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 92
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 91
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 86
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 86
Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation 83
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 82
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 82
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 81
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 80
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 79
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 78
The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. 77
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 77
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 77
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. 74
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 74
A hydrogen-sulfide releasing derivative of mesalamine exhibits markedly enhanced anti-inflammatory effects in experimental colitis 74
Role of the FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases 73
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 73
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. 73
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 73
Proteinase activated receptor (PAR)-2 protects against colitis in mice. Evidence for direct modulation of lamina propria T lymphocytes. 73
Gene Expression Changes Induced by HIPEC in a Murine Model of Gastric Cancer 73
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 71
Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons 71
Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA 70
Nitric oxide protects againist HIV gp 120 endothelial injury. 70
Critical role of toll-like receptors in modulating GM-CSF activity in rodent models of colitis 69
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 69
Proteinase activated receptor (PAR)-2 agonistic peptide protects from Th-1 mediated liver injury in mice. 68
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. 68
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 66
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 66
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin. 65
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. 65
COX-2 selective inhibitors cause gastric damage in aspirin treated rats. Protective effect of nitroaspirin (NCX-4016). 65
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. 64
NCX-1000, an NO derivative of UDCA, releases NO and protects against portal hypertension by inhibiting hepatic stellate cell contraction. 64
The third gas: H2S regulates perfusion pressure in both theisolated and perfused normal rat liver and in cirrhosis. 63
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 63
VLA-1 immunoneutralization protects against colon damage in a mouse model of colitis 62
Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis 62
FXR an emerging therapeutic target for the treatment of atherosclerosis. 61
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 61
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 60
Inhibition of hydrogen sulfide generation contributes to gastric injury caused byanti-inflammatory nonsteroidal drugs. 60
Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. 60
Farnesoid-X-receptor (FXR) ligands induce a small heterodimer partner (SHP)-dependent upregulation of PPAR-gamma in hepatic stellate cells and in rat model of liver fibrosis. 60
NCX-999, a NO-releasing derivative of UDCA, modulates hepatic stellate cells and reduces vasomotor response to nor-epinefrine in intact rats 60
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 59
FXR Activation Reverses Insulin Resistance and Protects Against NASH Development 59
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 58
The bile acid receptor FXR is a modulator of intestinal innate immunity. 58
The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. 57
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 57
The nuclear receptor SHP (small heterodimer partner) mediates inhibitory effects of farnesoid-X-receptor (FXR) on hepatic stellate cells and protects against liver fibrosis in rodents. 55
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 55
The CCR5 Antagonist Maraviroc Reduces the Potential for Gastric Cancer Dissemination in Rodent Models of Peritoneal Metastasis 55
Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxidereleasing derivative of mesalamine in rodent colitis. 54
Protective effects of granulocyte macrophage colony stimulating factor (gm-Csf) in Hapten-induced colitis 53
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 53
Molecular Determinants of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Model of Peritoneal Gastric Cancer Carcinogenesis 52
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. 51
Co-administration of nitric oxide-aspirin (NCX-4016) andaspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. 50
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 50
Celecoxib exacerbates gastrointestinal damage induced by aspirin but not by NO-aspirin (NCX-4016): A randomised, parallel group, blind-observer endoscopic study. Evidence for a protective role of NO in the gastrointestinal mucosa 50
‘The Farnesoid X Receptor Promotes Adipocyte Differentiationd regulates adipose cell function in vivo’ 49
Heat shock proteins as key biological targets of the marine natural cyclopeptide perthamide 49
The Nuclear Receptor SHP Mediates Inhibition of Hepatic Stellate Cells by FXR and Protects Against Liver Fibrosis 47
The Farnesoid X Receptor Promotes Adipocyte Differentiation and Regulates Adipose Cell Function in Vivo 47
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. 47
Enhanced anti-inflammatory activity of hydrogen sulfide releasing derivative of mesalamine in rodent models of colitis, involves direct inhibition of Nf-kappa B 46
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 46
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 44
The bile acid sensor FXR regulates insulin transcription and secretion. 44
Gastrointestinal safety and anti-inflammatory activity of HCT-1026, NO-releasing flurbiprofen, in healthy humans volunteers 42
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 41
Plakilactones from the Marine Sponge Plakinastrella mamillaris. Discovery of a New Class of Marine Ligands of Peroxisome Proliferator-Activated Receptor gamma 41
Inhibition of NF-kB by a PXR-Dependent Pathway Mediates Counter-regulatory Activities of Rifaximin on Innate Immunity in Intestinal Epithelial Cells 41
FXR Activation Corrects Immune-Dysfunction and Attenuates Inflammation in a Rodent Model of Hepatitis 37
Modification of Intestinal Microbiota by VSL#3 Protects Against Development of Pain in the Neonatal Maternal Separation Model. a Whole Genome Array Investigation 37
Totale 7.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021418 0 0 0 0 0 37 50 8 74 20 70 159
2021/2022877 15 152 9 32 32 120 5 274 4 8 75 151
2022/20231.563 116 295 8 154 114 173 1 84 556 0 50 12
2023/2024509 35 67 36 4 4 4 109 36 32 17 104 61
2024/20251.327 10 117 53 46 212 49 28 88 252 76 221 175
2025/20261.276 190 144 176 264 351 151 0 0 0 0 0 0
Totale 7.186